Technical Specifications Compound: BPC-157 (Synthetic Pentadecapeptide) Format: Lyophilized peptide powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White lyophilized powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory experimentation In-vitro scientific research Biochemical and molecular studies Non-human preclinical model development Institutional or academic research programs Not intended for: Human or animal consumption Injection, ingestion, inhalation, or topical use Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada, FDA, or any regulatory authority for clinical use
The effects of coronavirus on human nasal ciliated respiratory epithelium
Vin ung lm trng da Glutathione Warnke L-Glutathione Thnh phn L-Glutathione: Ngn chn s hnh thnh melanin, gip lm trng da v gim thiu khuyt im
Although these medications improve overall glycemic control, the combination of reduced food intake, delayed gastric emptying, and enhanced insulin secretion could theoretically affect glucose availability
It activates two of the same three receptors (GLP-1 and GIP), missing only the glucagon pathway
